Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Dermatol Sci ; 11(3): 214-22, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8785173

ABSTRACT

Secretory IgA (sIgA) is a major protective factor in the mucosal immune system because of its great ability to form complexes with bacteria. Secretory component (SC) is an 80-kDa glycoprotein, a component of sIgA, which functions as a polymeric immunoglobulin receptor for IgA and aids the secretion of sIgA from the epithelial surface. We studied SC production by keratinocytes which were involved in the inflammatory process using interferon-gamma (IFN-gamma) as one of the major inflammatory promoters produced by helper T cells. Using two human squamous cell carcinoma cell lines (HSCs) and normal human keratinocytes (NHKs), results from flow cytometric analysis, enzyme-linked immunosorbent assay (ELISA), and Northern blotting revealed that HSCs produced SC when stimulated with IFN-gamma, although their responses differed; one line exhibited enhanced SC production whereas the production in the other line was suppressed. NHKs also exhibited SC expression on the cell surface by means of immunocytochemical analysis, flow cytometry and ELISA, however the responses were also different in each strain. Although the reason for the diversity of SC expression on keratinocytes is not clear, these differences may influence epidermal sIgA secretion level.


Subject(s)
Interferon-gamma/pharmacology , Keratinocytes/metabolism , Receptors, Polymeric Immunoglobulin/biosynthesis , Secretory Component/biosynthesis , Base Sequence , Carcinoma, Squamous Cell , Dose-Response Relationship, Immunologic , Humans , Immunohistochemistry , Keratinocytes/drug effects , Male , Molecular Sequence Data , Receptors, Polymeric Immunoglobulin/drug effects , Secretory Component/drug effects , Skin Neoplasms , Tumor Cells, Cultured
2.
Dig Dis Sci ; 38(6): 1091-8, 1993 Jun.
Article in English | MEDLINE | ID: mdl-8508705

ABSTRACT

To evaluate the role of dietary polyamines in maturation of the rat small intestine, spermine was given orally twice daily to suckling pups from day 10 to day 14 postpartum at different doses: 0, 0.2, 0.5, 1, 2.5, and 5 mumol/dose. Compared to saline treated controls, spermine (5 mumol) produced significant increases in mucosal mass parameters (+12 to +57%, P < 0.05), induced prematurely an adult pattern of microvillous enzymes, and enhanced, respectively, by 19- and 3.5-fold (P < 0.01 vs controls) the concentration of the secretory component of p-immunoglobulins in villous and crypt cells. The response of microvillous enzymes (lactase, sucrase, maltase, and aminopeptidase) to spermine was dose-dependent and -specific since oral administration of arginine (5 mumol) or ornithine (5 mumol) was without effect. Intestinal changes were found to be significant (P < 0.05) for doses of spermine exceeding 1 mumol/day, which is in the range of the amount of polyamines provided by solid pellets at weaning (0.4 mumol/g). However, intestinal changes were undetectable at the physiological amounts of polyamines consumed by pups from rat milk during the suckling period (less than 0.3 mumol/day). Consistent with a direct effect of spermine on the intestinal cell, the cytosolic activity of ornithine decarboxylase was depressed by 27-fold (P < 0.005 vs controls) in the jejunum, while inhibition of ornithine decarboxylase by alpha-difluoromethylornithine did markedly decrease but did not suppress the cell response to spermine. Alternately, plasma corticosteronemia, which was virtually absent by day 14 in controls, ranged between 1.4 and 4.6 micrograms/dl in 60% (N = 9) of the spermine-treated rats.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Diet , Intestinal Mucosa/drug effects , Intestine, Small/drug effects , Polyamines/pharmacology , Animals , Animals, Suckling , Dose-Response Relationship, Drug , Intestinal Mucosa/enzymology , Intestinal Mucosa/growth & development , Intestine, Small/enzymology , Intestine, Small/growth & development , Microvilli/drug effects , Microvilli/enzymology , Ornithine Decarboxylase/drug effects , Ornithine Decarboxylase/metabolism , Rats , Rats, Wistar , Secretory Component/drug effects , Secretory Component/metabolism , Sodium Chloride/pharmacology , Spermine/pharmacology , Weaning
3.
Hum Antibodies Hybridomas ; 1(3): 126-31, 1990.
Article in English | MEDLINE | ID: mdl-1966476

ABSTRACT

Previously, we reported that smokeless tobacco users have significantly higher levels of immunoglobulin A and J chain in whole saliva than non-tobacco users. Because there was no difference in levels of secretory component between the two groups, the proportion of secretory component/immunoglobulin A was significantly lower in users than non-users. There was no significant difference in antibody function. In the present study, we examined immunoglobulin A from whole saliva of users and non-users to determine the effect of smokeless tobacco on the ability of secretory component to bind to immunoglobulin A containing J chain. Whole saliva was passed over an affinity chromatography filter unit coupled with anti-alpha heavy chain-specific antibody followed by passage over a molecular sieve high-performance liquid chromatography column. Peaks were collected and examined for immunoglobulin A, J chain and secretory component by enzyme-linked immunosorbent assay. Saliva from users had three significantly larger peaks (3-4 fold) at 280 nm than non-users, confirming the presence of a higher concentration of immunoglobulin A in users. The secretory component/J chain and secretory component/immunoglobulin A ratios for the largest peak were significantly less in users. This indicates that smokeless tobacco has an effect on the ability of secretory component to bind to immunoglobulin A without a loss in antibody function. This may occur either prior to immunoglobulin A/J chain binding to secretory component receptors on secretory epithelial cells or internal to the epithelial cells. These studies provide further evidence for the role of secretory component in mucosal immunity.


Subject(s)
Immunoglobulin A, Secretory/metabolism , Immunoglobulin J-Chains/metabolism , Plants, Toxic , Salivary Glands/drug effects , Secretory Component/drug effects , Tobacco, Smokeless/pharmacology , Adolescent , Adult , Humans , Male , Peroxidase/analysis , Saliva/chemistry , Salivary Glands/enzymology , Salivary Glands/immunology , Secretory Component/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...